A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Study ROR-PH-302, ADVANCE CAPACITY, is designed to evaluate the effects of ralinepag therapy on exercise capacity as assessed by change in peak oxygen consumption (VO2) derived from cardiopulmonary exercise testing (CPET) after 28 weeks of treatment
Epistemonikos ID: ee245c0446622cd0cc891b4ec3c3d9b7d08cd947
First added on: May 22, 2024